30+ Years of Clinical Research · Plant-Based EU-Regulated Formulas · Reviewed by Marlen Arita — Master in Dermotricology
Clinical Dermotricology · Scalp Psoriasis & Plaque Psoriasis
Thick Plaques. Burning Itch.
Thick Plaques. Burning Itch.
A Scalp That Never
Fully Clears.
Scalp psoriasis affects up to 80% of psoriasis patients — and it's the most difficult presentation to treat because hair gets in the way of everything. This plant-based 9-component system tackles plaque dissolution, scalp rebalancing, barrier repair, and internal inflammation at the same time. No coal tar. No steroids. No prescription.
Get the Home Treatment — $424.89 →100% plant-based · EU-regulated · No steroids · No coal tar
You already know this pattern
The Prescription Clears It.
The Prescription Clears It.
You Stop. It Comes Back.
Sometimes Worse Than Before.
The standard treatment path for scalp psoriasis is well-worn: start with coal tar or salicylic acid shampoos, escalate to prescription clobetasol (Clobex), maybe try roflumilast foam if you can get it, and eventually discuss biologics if nothing holds. Each option works to varying degrees — while you're using it.
The problem is that psoriasis is a systemic autoimmune condition. The IL-23/IL-17 inflammatory axis driving your scalp plaques is the same one linked to cardiovascular disease, psoriatic arthritis, and metabolic syndrome. No topical shampoo — no matter how strong — addresses that systemic driver. Which is why, the moment you stop, the cycle restarts.
Thick, silvery-white plaques on the scalp
Plaques extending onto forehead, neck, or ears
Intense burning itch — worse at night or with stress
Temporary flaking hair — not true hair loss
Condition cleared, then returned — multiple times
Coal tar smell and mess puts you off using it consistently
Looking for a steroid-free long-term management option
Family history of psoriasis, psoriatic arthritis, or IBD
80%
of the 9 million U.S. psoriasis patients experience scalp involvement — the most common and often most distressing presentation¹
30%
of psoriasis patients develop psoriatic arthritis — driven by the same IL-17/IL-23 systemic inflammation that causes scalp lesions²
May 2025
FDA approved roflumilast foam 0.3% (Zoryve) as the first new steroid-free topical for scalp psoriasis — prescription only³
The biology behind why scalp psoriasis is different
Why Scalp Psoriasis Is Harder
Why Scalp Psoriasis Is Harder
Than Psoriasis Anywhere Else
Scalp psoriasis shares the same autoimmune mechanism as plaque psoriasis elsewhere on the body — the IL-23/IL-17 axis drives keratinocyte hyperproliferation, producing skin cells 10x faster than normal, creating the thick, silvery plaques characteristic of the condition. But the scalp presents three additional challenges that make it uniquely resistant to standard treatment.
The 2025–2026 clinical consensus
A 2025 network meta-analysis of scalp psoriasis randomized controlled trials confirmed that scalp psoriasis "is often resistant to topical and conventional systemic agents" and that there is no consensus "gold standard" treatment — making it the most underserved presentation in the broader psoriasis landscape.4
Challenge 01
Hair Acts as a Barrier
Shampoos and creams must penetrate through hair to reach the scalp. Thick plaque buildup further blocks absorption. Without a dedicated plaque pre-softening step, no active formula reaches the affected tissue — which is why KS115 is the first step in this protocol.
Challenge 02
Sebum-Rich Environment Feeds Flares
The scalp is the most sebum-dense zone on the body. Excess sebum creates an inflammatory microenvironment that sustains Malassezia overgrowth and compounds the psoriatic inflammatory loop — which is why microbiome rebalancing is essential alongside plaque treatment.
Challenge 03
Cosmetic Compliance Problem
Coal tar smells. Clobetasol foam leaves residue. Patients who don't tolerate or consistently use their treatment don't get results. The plant-based system is formulated for daily use without the sensory compliance barriers that make pharmaceutical options hard to sustain.
Challenge 04
The Systemic Driver Is Untouched
Every topical treatment — steroid, coal tar, or botanical — addresses the scalp surface. The IL-23/IL-17 inflammatory axis that triggers the cycle runs systemically. Internal support (dePure, Revital) addresses the nutritional and detox environment that sustains chronic inflammation.
Honest comparison
Standard Scalp Psoriasis Treatments
Standard Scalp Psoriasis Treatments
vs. A Complete System
| Approach | Mechanism | Effectiveness | Limitations |
|---|---|---|---|
| Coal Tar Shampoos (T/Gel, MG217) | Slows keratinocyte hyperproliferation, reduces scaling | Moderate OTC — NPF-recognized; best for mild maintenance | Strong odor; discolors light hair; no plaque pre-treatment; no internal component |
| Salicylic Acid (T/Sal, MG217) | Keratolytic — loosens and removes scale buildup | Good for scale removal; weaker anti-inflammatory effect | Surface-only; no antifungal; no barrier repair; strips scalp if overused |
| Clobetasol Shampoo (Clobex) — Rx | Potent corticosteroid — suppresses inflammation fast | Strong for moderate-severe cases; fast clearance | Prescription required; adrenal suppression risk with overuse; hair thinning; rebound flare on stopping |
| Roflumilast Foam 0.3% (Zoryve) — Rx | PDE-4 inhibitor — non-steroidal anti-inflammatory; FDA-approved May 2025 for scalp | Strong steroid-free option; once-daily; well-tolerated in hair-bearing areas | Prescription required; newer long-term data; topical only; no internal support |
| Biologics (Skyrizi, Taltz, Humira) | IL-17/IL-23 blockade — addresses the systemic driver | Excellent for moderate-severe; 83–100% DLQI 0/1 in scalp trials | Injection; $25,000+/year without insurance; immunosuppression; infection risk |
| Kapyderm Scalp Psoriasis Treatment | Plaque dissolution + antifungal + barrier repair + internal inflammation support | Comprehensive clinical system for mild-moderate; complement to pharmaceutical treatment | No steroids · No coal tar · No prescription · 9 components addressing all drivers |
Why this is more than a scalp condition
Psoriasis Is Systemic.
Psoriasis Is Systemic.
The Scalp Is Where It Shows.
The same IL-17/IL-23 inflammatory cascade driving your scalp plaques contributes to a documented set of systemic comorbidities. This is the clinical rationale for why internal support is part of a complete scalp psoriasis management approach — not just an add-on.
Psoriatic Arthritis
Affects up to 30% of psoriasis patients. Joint inflammation driven by the same IL-17 pathway. Often develops years after skin onset.
Cardiovascular Disease
Severe psoriasis reduces life expectancy by 3–4 years through shared inflammatory pathways with atherosclerosis.
Metabolic Syndrome
Higher prevalence of obesity, insulin resistance, and dyslipidemia in psoriasis patients — linked to TNF-α/IL-17 systemic inflammation.
Depression & Anxiety
Documented higher rates of anxiety, depression, and social avoidance — particularly in scalp and facial presentations where visibility is unavoidable.
The complete clinical system
The Scalp Psoriasis Home Treatment
Kapyderm USA — Intensive Follicular & Plaque Therapy System
Scalp Psoriasis Home Treatment
$424.89
9 components — 7 topical, 2 internal. The most comprehensive plant-based scalp psoriasis system available. EU-regulated. No coal tar, no corticosteroids, no prescription required.
1
Dandruff & Dry Hair Base CleanserTopical
A deeply hydrating therapeutic shampoo that lifts scale, clarifies the scalp, and prepares the tissue for active absorption — used with Ampoule N mixed directly into the wash for enhanced anti-inflammatory action.
2
Ampoule NTopical
A concentrated anti-inflammatory serum mixed directly into the Dandruff Cleanser during washing — delivering botanical anti-inflammatory actives directly to the scalp tissue during the most receptive point in the protocol (post-cleansing, when the follicle is open).
3
KS115Topical
The plaque pre-treatment step — an intensive keratolytic formula engineered to soften, loosen, and dissolve thick hyperkeratotic plaques before any other active is applied. This step is the critical differentiator for moderate-to-severe scalp psoriasis — without plaque dissolution first, nothing else penetrates.
4
Essential Oil K1Topical
A concentrated botanical essential oil blend delivering deep lipid restoration and potent anti-inflammatory action to the scalp. Regulates the accelerated mitosis (overproduction) of skin cells, calms irritation, and protects the hydrolipid film — applied daily after KS115 during Phase 1.
5
Base TonicTopical
A stimulating topical solution that maintains proper scalp microflora balance and supports microcirculation. Used in Phase 2 (once plaques have cleared) in combination with Fungi-Activ and Special K Cream to maintain the healthy scalp environment.
6
Fungi-ActivTopical
Botanical microbiome rebalancing complex — transitions from supportive to primary antifungal in Phase 2 once plaques have cleared, maintaining the healthy scalp ecology that prevents the sebum-rich environment from re-triggering Malassezia-mediated flares.
7
Special K CreamTopical
A barrier-repair and restorative cream sealing structural lipid gaps after the active treatment steps — protecting recovering scalp tissue, locking in botanicals, and maintaining the barrier integrity needed to prevent environmental triggers from re-initiating the inflammatory cycle.
8
dePure SupplementInternal
An internal botanical detox formula (Artichoke, Boldo, Dandelion) supporting liver function and systemic detoxification — addressing the internal inflammatory load that perpetuates chronic autoimmune skin conditions from within. Taken twice daily.
9
Revital SupplementInternal
High-density nutritional support delivering vital cellular vitamins and dermal repair nutrients — supporting skin regeneration and immune regulation systemically. Taken nightly to support overnight cellular repair.
How to use it
Two-Phase Protocol
Phase 1 focuses on plaque dissolution and active clearance. Phase 2 shifts to maintenance and relapse prevention. The transition happens when plaques have fully cleared.
Phase 1 — Active Clearance
Daily until all plaques have resolved
- Morning, afternoon & evening: Apply KS115 to plaque areas → then apply Essential Oil K1 → finish with Special K Cream
- Daily wash: Mix Dandruff & Dry Hair Base Cleanser + Ampoule N → apply to scalp, leave for several minutes, rinse
- Internal — morning: Take 2 dePure capsules
- Internal — afternoon: Take 2 dePure capsules
- Internal — evening: Take 2 Revital capsules
Phase 2 — Maintenance & Prevention
Once plaques have fully resolved — continue until lesions are gone
- Replace KS115 with Fungi-Activ + Base Tonic mixed together with Special K Cream and K1 Oil — apply daily
- Continue daily wash with Dandruff & Dry Hair Base Cleanser + Ampoule N
- Continue internal supplement cycle (dePure + Revital)
30+ years of European research
100% plant-based formulas
EU-regulated manufacturing
No steroids · No coal tar
9 components · 2-phase protocol
Frequently Asked Questions
Can scalp psoriasis be treated without steroids?
Yes. For mild to moderate scalp psoriasis, non-steroidal options are increasingly the clinical preference. The FDA approved roflumilast foam 0.3% (Zoryve) in May 2025 as the first new prescription non-steroidal topical specifically for scalp and hair-bearing psoriasis. This plant-based system is a non-prescription alternative addressing the same surface and systemic factors without corticosteroids — appropriate for mild-moderate disease, or as a complement to pharmaceutical treatment for more severe cases.
Why does scalp psoriasis keep coming back?
Because psoriasis is an autoimmune condition driven by the IL-23/IL-17 cytokine axis — a self-perpetuating inflammatory loop that continues between visible flares. Topical treatment suppresses the surface lesion without addressing the systemic inflammatory environment that re-triggers it. The internal components of this system (dePure + Revital) address the systemic detox and nutritional layer that topical-only approaches miss entirely.
How does this compare to coal tar shampoos like T/Gel?
Coal tar shampoos slow cell turnover and reduce scaling — effective for mild maintenance but single-mechanism, strong-smelling, and purely surface-level. This system adds five additional layers: a dedicated plaque pre-dissolving step (KS115), deep botanical anti-inflammatory action (K1 Oil + Ampoule N), microbiome rebalancing (Fungi-Activ + Base Tonic), barrier repair (Special K Cream), and internal systemic support (dePure + Revital). For anyone who has found coal tar insufficient or intolerable, this system addresses what it doesn't.
Is scalp psoriasis linked to other health conditions?
Yes — psoriasis is a systemic inflammatory disease. The same IL-17/IL-23 pathway driving scalp plaques contributes to psoriatic arthritis (in up to 30% of patients), cardiovascular disease, metabolic syndrome, and depression through shared inflammatory mechanisms. Severe psoriasis is associated with a reduction in life expectancy of 3–4 years through these comorbidities. This clinical reality is why internal systemic support is a rational part of management — not just surface-level plaque treatment.
What is the difference between scalp psoriasis and seborrheic dermatitis?
Scalp psoriasis produces thick, silvery-white, well-defined plaques — often extending beyond the hairline. Seborrheic dermatitis produces greasy, yellowish, less-defined flaking driven by Malassezia yeast overgrowth. Psoriasis is autoimmune (IL-23/IL-17); seborrheic dermatitis is microbial and barrier-mediated. They can coexist — called sebopsoriasis — and this system addresses both mechanisms simultaneously, making it suitable for either diagnosis or overlap presentations.
Address the Plaques.
Address the System Behind Them.
The Scalp Psoriasis Home Treatment targets plaque dissolution, microbiome rebalancing, barrier repair, and internal inflammation — plant-based, EU-regulated, no coal tar, no steroids, no prescription required.
100% plant-based · EU-regulated · No coal tar · No steroids · No prescription
Clinical References
- HCPLive. Psoriasis in 2025: Year in Review. December 2025. 9 million U.S. patients; 80% scalp involvement; roflumilast foam May 2025 approval. hcplive.com
- PMC8019008. Interleukin-17 and IL-23: Mechanisms in Psoriasis and Comorbidities. IL-17/IL-23 axis; 30% psoriatic arthritis prevalence; 3–4 year life expectancy reduction. PMC8019008
- AJMC. Top 5 Most-Read Psoriasis Content of 2025. Roflumilast (Zoryve) foam 0.3% FDA approval May 2025 for scalp psoriasis. ajmc.com
- PMC12090945. Biologic and Non-Biologic Therapies for Scalp Psoriasis: Network Meta-analysis of RCTs. 2025. "Often resistant to topical and conventional systemic agents — no consensus gold standard." PMC12090945
- AbbVie / AAD 2026. Risankizumab in Scalp Psoriasis — UnlIMMited Trial. 83.3–100% DLQI 0/1 at 16 weeks. abbvie.com
- Frontiers in Immunology. Skin Immune Microenvironment in Psoriasis: From Bench to Bedside. August 2025. IL-23/IL-17 axis, comorbidities. frontiersin.org